Collectively, our data demonstrated frequent down-regulation and clinical significance of AKR7A3 in HCC, as well as its strong tumor suppressive functions and inhibition of chemoresistance, which could be attributed to the attenuation of ERK, c-Jun and NF-κB signaling pathways. Here, AKR7A3 is linked to hepatocellular carcinoma.